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Francisella tularensis is a highly virulent bacterial pathogen and the causative agent of tularemia. 
Perhaps the most impressive feature of this bacterium is its ability to cause lethal disease 
following inoculation of as few as 15 organisms. This remarkable virulence is, in part, attributed 
to the ability of this microorganism to evade, disrupt, and modulate host immune responses. 
The objective of this review is to discuss the mechanisms utilized by F . tularensis to evade and 
inhibit innate and adaptive immune responses. The capability of F . tularensis to interfere with 
developing immunity in the host was appreciated decades ago. Early studies in humans were 
the first to demonstrate the ability of F . tularensis to suppress innate immunity.  This work noted 
that humans suffering from tularemia failed to respond to a secondary challenge of endotoxin 
isolated from unrelated bacteria. Further, anecdotal observations of individuals becoming 
repeatedly infected with virulent strains of F . tularensis suggests that this bacterium also 
interferes with the generation of adequate adaptive immunity. Recent advances utilizing the 
mouse model for in vivo studies and human cells for in vitro work have identified specific bacterial 
and host compounds that play a role in mediating ubiquitous suppression of the host immune 
response. Compilation of this work will undoubtedly aid in enhancing our understanding of the 
myriad of mechanisms utilized by virulent F . tularensis for successful infection, colonization, and 
pathogenesis in the mammalian host.
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host, or those previously exposed to F. tularensis, serum antibod-
ies may also participate in extracellular detection of the invading 
organism. Once in contact with a suitable host cell, the bacterium 
faces additional hurdles in place to control bacterial replication. 
Two of the most formidable host defense systems faced by F. tula-
rensis are the reactive oxygen and reactive nitrogen systems, ROS 
and RNS respectively. ROS and RNS can be triggered by multiple 
mechanisms. Thus, the bacterium is forced to possess an arsenal 
of evasion strategies to either prevent triggering and/or, in some 
circumstances, dismantling the machinery of ROS and RNS in 
the host. In this review we will discuss specific strategies utilized 
by F. tularensis to successfully evade detection by the host in the 
extracellular space as well as disruption of the ROS and RNS in the 
intracellular compartment that facilitates replication, dissemina-
tion, and virulence of this bacterium.
Interference wIth host response In the 
extracellular space
serum medIated KIllIng
Depending on the immune status of the host, serum, and/or plasma 
can mediate killing of bacteria via two often intertwined path-
ways. First, both naïve and immune animals possess the comple-
ment system. The complement system, as originally described by 
Jules Bordet, is comprised of heat-labile components present in 
plasma that enhance phagocytosis and killing of microorganisms. 
Today, we understand that complement can act independently, or 
IntroductIon
Francisella tularensis is a small, non-motile, Gram negative bac-
terium, and the causative agent of tularemia. It is also a facul-
tative intracellular pathogen. There are four primary subspecies 
of F. tularensis. F. tularensis subsp. mediasiatica and novicida are 
attenuated in humans. F. tularensis subsp. holarctica causes a mild 
disease in people. F. tularensis subsp. tularensis causes severe dis-
ease in humans and other mammals following exposure to small 
numbers (<15 bacteria) of bacteria. F. tularensis can be transmitted 
following exposure to aerosols, contaminated biological products, 
e.g., animal carcasses, ingestion of contaminated water, or from 
the bite of infected arthropod vector (as reviewed, Nigrovic and 
Wingerter, 2008). Once inside the host F. tularensis can invade 
multiple cell types. However, antigen presenting cells (APC) such 
as macrophages and dendritic cells appear to be the primary cell 
types targeted by the bacterium at the outset of infection (Bosio 
and Dow, 2005; Bosio et al., 2007; Hall et al., 2007, 2008; Bar-Haim 
et al., 2008).
As an intracellular pathogen, F tularensis must confront anti-
microbial defenses present in the host at multiple steps during 
infection. Subversion of host immune responses begins at the site 
of infection. Depending on the route of entry, and prior to meet-
ing a desirable host target cell, the bacterium must first evade kill-
ing by serum components designed to eliminate pathogens in the 
extracellular space. These serum components can include comple-
ment present in both naïve and immune hosts. In the vaccinated Frontiers in Microbiology  |  Cellular and Infection Microbiology    February 2011  | Volume 2  | Article 9  |  2
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of immune serum was an effective treatment for patients regardless 
of the form, e.g., pneumonic versus ulceroglandular, of tularemia 
they had. More recent studies using the mouse model of pneumonic 
tularemia have demonstrated that passive transfer of both immune 
serum and specific monoclonal antibodies can protect against a 
lethal challenge of the Live Vaccine Strain (Kirimanjeswara et al., 
2007; Savitt et al., 2009). However, passive transfer of antibodies 
failed to increase survival of animals challenged with fully virulent, 
Type A strains of F. tularensis although extended mean time to death 
was noted (Kirimanjeswara et al., 2008).
The failure of antibodies to contribute to survival of Type A 
infections in mice is not understood. One explanation may lie with 
the bacterium itself. Recently, our laboratory has demonstrated 
that antibody mediated opsonization of LVS and the Type A strain 
F.    tularensis  subsp.  tularensis  strain  SchuS4  resulted  in  similar 
phagocytosis of each strain of bacterium by mouse macrophages. 
Importantly, we also demonstrated that phagocytosis of antibody 
opsonized bacteria provoked a pro-inflammatory response from 
infected macrophages (Crane et al., 2009). This was notable since 
it is widely accepted that one of the primary virulence mechanisms 
possessed by F. tularensis is its ability to infect host cells without elic-
iting pro-inflammatory cytokines such as TNF-α and IL-6 (Telepnev 
et al., 2003; Bosio and Dow, 2005; Chase et al., 2009). Production of 
these cytokines during infection is important because they could 
contribute to the activation of the ROS and RNS pathways that 
participate in control of F. tularensis infection (Fortier et al., 1992). 
Thus, the ability of both antibody opsonized LVS and SchuS4 to be 
phagocytosed by host cells and induce cytokine production from 
infected macrophages did not explain the failure of passively trans-
ferred antibody to protect against SchuS4 infections in mice.
To address this issue we turned to factors available in the host, 
but not routinely present among in vitro culture systems, which 
may influence the interaction of F. tularensis with antibody. One 
such factor is the host serine protease plasmin. Plasmin is gener-
ated following interaction of components of the host plasminogen 
system. The host plasminogen system is a key proteolytic system 
for dissolution of fibrin clots, migration of host cells through tis-
sues, and the penetration of those cells through protein barriers (as 
reviewed, Plow et al., 1995). Many bacteria have been noted to bind 
plasminogen and plasmin and utilize these host proteins to enhance 
virulence (Lahteenmaki et al., 2001). Indeed, virulent F. tularensis, 
but not attenuated LVS, bound the active protease plasmin. Further, 
plasmin coated F. tularensis inhibited opsonization by Francisella 
specific antibody. The reduced ability of antibody to opsonize plas-
min coated, virulent F. tularensis resulted in production of signifi-
cantly less cytokines compared to opsonized, non-plasmin coated 
controls (Crane et al., 2009). These data suggested that an additional 
mechanism by which virulent F. tularensis subverts host immune 
responses is by utilizing host proteolytic machinery to degrade 
antibodies that may participate in protective responses.
Interference wIth host response at the cellular 
level
InteractIon wIth cell surface receptors
Once the bacterium has traversed the serum and contacted a target 
host cell, a series of new hurdles that may interfere with successful 
colonization of the host confront F. tularensis. Cellular defense often 
in   conjunction with, antibodies to control pathogens. The com-
plement system itself is made up of three pathways: the classical 
pathway, the mannose-binding lectin (MBL) pathway, and the 
alternative pathway. Each of these pathways can interact directly 
with pathogens, although the initial proteins and complexes that 
bind bacterial surfaces vary. Regardless of the pathway or proteins 
that initially target the microorganism, the pathways converge with 
the generation of C3 convertase, an enzyme that cleaves C3 to C3b. 
C3b is the primary effector of the complement system. This protein 
can act in two ways. First, C3b may directly opsonize pathogens to 
facilitate their phagocytosis and clearance from the host. Second, 
C3b plays a role in the generation of C5b. C5b forms the base of 
the membrane attack complex (MAC) which, when assembled, can 
induce direct lysis of the bacterium. These pathways are extremely 
well studied and there are many excellent reviews and textbook 
chapters that discuss them in detail (Janeway et al., 2005). Thus, 
only aspects of these systems that have been shown to be directly 
involved in control of F. tularensis will be discussed here.
During the early years of research on immunity to Francisella, 
it was noted that these microorganisms were relatively resistant to 
killing following exposure to human serum (Lofgren et al., 1983). 
This suggested that one mechanism of immune evasion by virulent 
F. tularensis was resistance to the assembly of the MAC on their 
outer membrane. The specific mechanism by which F. tularensis 
is resistant to the assembly of MAC is not completely clear. In one 
study, the presence of capsule contributed to the evasion of killing 
by serum components (Sandstrom et al., 1988). However, it has 
also been shown that F. tularensis binds another serum component, 
Factor H (Ben Nasr and Klimpel, 2008). In that study, Factor H 
served to cleave C3b to its inactive form iC3b. Generation of the 
iC3b under these conditions led to inefficient assembly of the MAC. 
Importantly, generation of iC3b served a second function for the 
bacterium. Inactive C3b serves as an opsonin for pathogens present 
in the host vascular system. Pathogens coated in iC3b are targeted 
for phagocytosis by various cell types which encode the receptors 
that are capable of interacting with this protein, including macro-
phages, dendritic cells, and neutrophils (Plow and Zhang, 1997). 
The two primary receptors noted to interact with iC3b are the 
complement receptor complex 3 (CR3) which consists of CD11b 
and CD18 and complement receptor complex 4 (CR4) that consists 
of CD11c and CD18. Indeed, F. tularensis is more efficiently phago-
cytosed by macrophages and dendritic cells following opsonization 
with iC3b and it has been shown to utilize both CR3 and CR4 in 
this process (Ben Nasr et al., 2006). Thus, the ability of F. tularensis 
to participate in the generation of iC3b serves at least two roles. 
First, it interferes with the deposition of the MAC on the surface 
of the bacterium and second it facilitates uptake by cells which are 
favored by the bacterium for replication.
In addition to complement proteins, the immune host may also 
possess Francisella specific antibodies. These antibodies can inter-
fere with the ability of bacteria to infect host cells. Although the role 
for antibody in Francisella immunity has been controversial, classi-
cal studies by Foshay demonstrated that passive transfer of hyper-
immune serum into humans infected with virulent F. tularensis 
greatly enhanced their recovery (Foshay et al., 1947). Further, this 
therapy was at least as effective as administration of streptomycin. 
Importantly, as described in Foshay’s manuscript, passive transfer www.frontiersin.org  February 2011  | Volume 2  | Article 9  |  3
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can impact replication the bacterium can ultimately overcome this 
response. The potential mechanisms by which F. tularensis overcomes 
the inflammatory response is discussed below.
A second strategy used by F. tularensis to evade detection at 
the level of the host cell surface is to engage receptors that fail to 
induce and/or suppress inflammatory responses. Utilization of the 
MR and CR3 are considered fairly innocuous routes of entry for 
intracellular pathogens since neither are associated with induction 
of signaling cascades that result in production of pro-inflammatory 
cytokines (Aderem and Underhill, 1999; Zhang et al., 2005). It has 
been demonstrated that, depending on the environment or condi-
tions of infection, F. tularensis can utilize both MR and CR3 for 
entry into host cells. As discussed above, when opsonized with 
serum F. tularensis binds iC3b and gains entry into host cells via 
the CR3 receptor. Under non-opsonizing conditions, similar to 
that found in airways, F. tularensis utilizes the MR for entry in 
macrophages (Schulert and Allen, 2006). Therefore, F. tularensis 
evades detection at the point of entry in the host in three ways: 
(i) the bacterium has modified cell surface structures that enable 
it to avoid interaction with host receptors that are associated with 
induction of inflammation, e.g., TLR4; (ii) it targets cells that lack 
co-receptors which facilitate binding to receptors that could alert 
the host cell to invasion; and (iii) it utilizes receptors that fail to 
initiate production of pro-inflammatory cytokines.
the Intracellular compartment
Host defense by invading pathogens is not limited to detection of 
the microorganism at the surface of the cell. Mammals also possess 
an array of defense complexes, intracellular receptors, and signal-
ing pathways that enable the host to control and eliminate the 
unprepared pathogen. Thus, as an intracellular pathogen, survival 
and replication of F. tularensis relies on its ability to interfere or 
modulate these intracellular defense mechanisms.
As observed in other bacterial infections, F. tularensis is sus-
ceptible to killing by reactive oxygen and reactive nitrogen species 
generated by the host (Fortier et al., 1992; Bosio and Elkins, 2001; 
Ireland et al., 2010). Thus, it is unsurprising that F. tularensis is capa-
ble of evading destruction by these toxic molecules. The evasion of 
products associated with an oxidative burst can be partially attrib-
uted to the neutralization of oxidative species by enzymes encoded 
by F. tularensis, e.g., catalase and superoxide dismutase (Lindgren 
et al., 2007). However, there is also evidence that F. tularensis is 
capable of directly interfering with the assembly of complexes in 
the host cell responsible for generating oxidative species. Allen and 
colleagues demonstrated that, following phagocytosis of opsonized 
F. tularensis by polymorphonuclear cells (PMN), the generation 
of superoxide anions via the NAPDH oxidase was actively inhib-
ited. They then demonstrated that F. tularensis directly interfered 
with the phosphorylation of the p47 subunit of the NADPH oxi-
dase. More recently, it was shown that interference with NADPH 
oxidase assembly occurred at two separate points. In addition to 
inhibiting activation of the p47 subunit, virulent F. tularensis also 
inhibited accumulation of the gp91phox/gp22phox heterodimer (also 
known as flavocytochrome b558) in neutrophils. Further, virulent 
F.   tularensis also suppressed the ability of human neutrophils to 
assemble the NADPH oxidase following exposure to unrelated 
stimuli (McCaffrey et al., 2010).
begins with the interaction of the pathogen with receptors present 
on the host cell surface. The vast majority of receptors that interact 
with invading pathogens are termed pattern recognition receptors 
(PRR) due to their ability to recognize and bind conserved motifs 
present on multiple microorganisms. These PRR include, but are 
not limited to, scavenger receptors (SR), mannose receptors (MR), 
C-type lectins, and toll-like receptors (TLR). In some circumstances 
co-receptors and/or binding partners are required to optimally 
induce signaling though these receptors. For example, CD14 is a 
promiscuous co-receptor that acts to enhance signaling through 
TLR4 and TLR2 (Ulmer et al., 1999; Jiang et al., 2000).
Typically, engagement of many PRR results in the secretion of 
multiple cytokines and chemokines by the host cell. These solu-
ble mediators then activate anti-microbial pathways and facilitate 
migration of effector cells to the site of infection. Thus, there are 
two strategies a pathogen may adopt to avoid engagement of these 
receptors. One is to possess ligands that fail to interact with the 
receptor or do so inefficiently. Another strategy is to engage recep-
tors that fail to promote strong inflammatory responses. Both of 
these strategies are utilized by F. tularensis.
For  example,  as  found  in  other  Gram  negative  bacteria, 
F.    tularensis  possesses  lipopolysaccharide  (LPS)  as  part  of  its 
outer membrane. However, unlike LPS associated with E. coli or 
Salmonella species, the LPS associated with Type A subspecies of 
Francisella is an extremely weak TLR4 agonist (Phillips et al., 2004; 
Duenas et al., 2006) The poor stimulatory activity of LPS associ-
ated with this subspecies is attributed to the presence of only four 
acyl groups on their LPS (Phillips et al., 2004). Optimal signaling 
of LPS through TLR4 requires at least six acyl groups (Park et al., 
2009). Thus, another mechanism by which F. tularensis evades 
detection by the host is modulation of ligands present on its sur-
face to poorly interact with PRR that aid in altering the host cell 
to invading pathogens.
In addition to LPS, Francisella possess other TLR agonists. For 
example, Tul4 is lipoprotein that induces signaling responses via 
TLR2 (Thakran et al., 2008). Tul4 is present on the surface of the 
bacterium and thus represents a ligand that could alert the host cell 
to the presence of F. tularensis prior to phagocytosis of the bacterium. 
Yet, despite the presence of Tul4 as an available TLR2 agonist, strong 
inflammatory responses are not observed in host cells infected with 
virulent F. tularensis. One explanation for lack of detection of Tul4 on 
the surface of F. tularensis by specific host cells may lie in the absence 
of co-receptors present on select target cells. As stated above CD14 
acts as a co-receptor to enhance interaction of microbial ligands for 
several PRRs including TLR2. At least two primary target cells of F. 
tularensis, alveolar macrophages and dendritic cells fail to express 
or, only express minimal concentrations of CD14 on their surface. 
Indeed, when dendritic cells were supplemented with soluble CD14 
they secreted several pro-inflammatory cytokines following infection 
with F. tularensis (Chase and Bosio, 2010). In vivo, addition of CD14 
at the time of intranasal infection induced production of TNF-α and 
IL-6 and was correlated with control of bacterial replication and dis-
semination (Chase and Bosio, 2010). However, it should be noted 
that despite early control of F. tularensis infection in mice receiving 
CD14, supplementation of this receptor in vivo did not result in 
increased survival (Chase and Bosio, 2010). Thus, while early detec-
tion of F. tularensis and induction of modest inflammatory response Frontiers in Microbiology  |  Cellular and Infection Microbiology    February 2011  | Volume 2  | Article 9  |  4
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colleagues demonstrated that LVS lacking a gene previously identi-
fied to be required for intracellular proliferation (RipA) provoked 
secretion of greater quantities of IL-1β and TNF-α in mouse macro-
phages and the human monocytic cell line, THP-1 cells (Fuller et al., 
2008; Huang et al., 2010). It was not determined if RipA encoded 
a protein that directly interfered with induction of inflammatory 
responses in these cells or if the heightened inflammatory response 
observed in LVS∆ripA mutants was a result of poorly replicat-
ing bacteria. Similarly, LVS∆mviN bacteria also elicited a stronger 
inflammatory response in mouse macrophages compared to wild 
type LVS (Ulland et al., 2010). However, unlike RipA, mviN was 
not required for intracellular replication of LVS. Thus, the effect 
mviN had on elicitation of inflammation was presumably not due 
to bacteria that were compromised for growth in the intracellular 
compartment. The role of RipA and mviN in infections mediated 
by virulent F. tularensis has not been explored. However, these data 
generated with LVS provided promising evidence that novel genes 
encoded by F. tularensis can contribute to the immunosuppression 
host cells.
concludIng remarKs
Francisella tularensis is a remarkable bacterial pathogen. In the 
early days of F. tularensis research, when scientists were first char-
acterizing the bacterium, it was apparent that the “success” of this 
pathogen was tied to its ability to modulate and evade the immune 
system. This modulation was evident in two central observations. 
First,  the  ability  of  this  microorganism  to  cause  acute,  lethal, 
disease in the mammalian host following exposure to relatively 
miniscule numbers of bacteria suggested it was capable of readily 
evading innate host defense mechanisms present at the outset and 
throughout the infection. Second, the lack of development of long 
lived immunity in laboratory workers who had survived a primary 
infection pointed to manipulation of adaptive immunity (Jellison, 
1974). As discussed herein, it is clear that F. tularensis possesses a 
myriad of mechanisms by which to manipulate immunity. Further, 
current data suggests that this subversion begins in the extracellular 
compartment and continues throughout the intracellular life cycle 
of the bacterium. We have just begun to uncover the collection of 
immune evasion strategies embodied by this organism. Due to 
the multiple pathways F. tularensis influences as it traverses host 
environment, continued research into the specific mechanisms 
by which F. tularensis evades, modulates, and suppresses the host 
immune response will undoubtedly enhance our understanding 
of tularemia, infectious disease, and regulation of host immunity 
as a whole.
In addition to directly interfering with assembly of the machin-
ery responsible for focusing degradative enzymes at invading path-
ogens, F. tularensis has the capability of modulating this response in 
an indirect fashion. It has been suggested that attenuated strains of 
F. tularensis induce alternative activation of macrophages (Shirey 
et al., 2008). One property of alternatively activated macrophages 
is a dampened ability to activate reactive nitrogen species (Gordon, 
2003). As described above RNS can contribute to the control of 
F. tularensis infections. Thus, provoking a state of alternative activa-
tion in host cells could give the invading bacterium an advantage for 
unrestricted replication in the host cell. However, it is not known 
if virulent strains of F. tularensis can provoke a similar response in 
resting macrophages. A more recent report provided evidence that 
F. tularensis inhibited oxidative burst via antioxidant scavenging 
systems associated with the bacterium (Melillo et al., 2010).
Pro-inflammatory cytokines such as TNF-α and IL-12 have been 
shown to contribute to the control of F. tularensis infections (Elkins 
et al., 1996, 2002). Some of these cytokines, e.g., TNF-α, may act 
directly on the APC to induce oxidative burst. Alternatively, other 
pro-inflammatory cytokines, e.g., IL-12, may act indirectly via the 
activation of effectors cells such T cells or NK cells to produce IFN-γ 
which then activates the APC. Thus, inhibition of the production 
and secretion of these pro-inflammatory cytokines by infected cells 
could also limit anti-microbial oxidative burst. The first evidence 
that F. tularensis was capable of modulating host cell production 
of cytokines was observed in humans infected with F. tularensis 
followed by exposure to endotoxin. Unlike uninfected controls, 
humans suffering from pneumonic tularemia failed to mount an 
inflammatory response following administration of endotoxin iso-
lated from unrelated bacteria (Greisman et al., 1963). Later, in vitro 
studies using the murine macrophage cell line J774 demonstrated 
that F. tularensis actively suppressed the ability of host cells to pro-
duce TNF-α in response to E. coli LPS (Telepnev et al., 2003). In this 
report, a 23-kDa protein was found to be essential for suppression 
of TNF-α and IL-1β production in J774 cells, although the specific 
mechanism by which this protein interfered with host cell function 
was not described. Later studies conducted by our laboratory dem-
onstrated that the F. tularensis mediated suppression of cytokine 
production also occurred following in vivo pulmonary infection 
(mirroring the original observations in humans) and, importantly, 
was extended to human dendritic cells (Bosio et al., 2007; Chase 
et al., 2009). The specific mechanism(s) by which virulent F. tula-
rensis interferes with the ability of host cells to mount inflammatory 
responses has not been fully elucidated, although it is a subject of 
intense study by our lab and others. Recent work by Huang and www.frontiersin.org  February 2011  | Volume 2  | Article 9  |  5
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